Medigen Biotechnology Corp.

NT$31.80As of Sun 8 Nov 2026, 12:00 UTC
TPEx:3176Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR (7.59%)
Div yield —
ROE (7.45%)
Biotechnology
Beta (5Y) 0.34
PE TTM —
TSR TTM 7.98%
Mkt cap NT$4.430B
ROIC (6.72%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$31
(3.17%)
(17.60%)
Hold 12|7|1|5|11
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.31
0.30
0.32
0.32
4.09%
(2.00%)
4.57%
8.79%
RevenueNT$M
555.3
542.3
543.6
571.6
12.80%
6.13%
6.67%
6.31%
Peers (US$133.8M)
Cap (US$)
PE
133.6M
—
Capital
TTM
5Y
10Y
Leveragex
1.332
(0.289)
(0.288)
EBIT/Intx
0.076
0.122
0.119
Own earn%
(84.00)
(71.19)
(66.50)
Sh yield%
7.84
33.13
32.29
Owners
Insiders/Inst%
14.14
34.94
Short interest%
3.90
SBC / revenue%
0.91
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
15–20
$1 testx
—
Incr. ROIC%
9